Clinical trial Recruiting at 1 site Observational Ages 18 and up

Assessing outcomes of cervical fusion with interfacet spacers

Official title: Clinical and Radiological Outcomes of Posterior Cervical Fusion Supplemented With Interfacet Spacers

Run by Ohio State University · NCT04041583 · Data updated 2026-11-12

This study is testing how well a new type of spacer works in helping patients recover from neck surgery and if it can prevent complications like nerve problems.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorOhio State University
Academic / other
Drugs / interventionsmethotrexate
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedSeptember 1, 2019
Main results expectedOctober 2028
Study endsOctober 2028
Registry record updatedOctober 16, 2026
Trial IDNCT04041583 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with symptomatic multi-level degenerative spondylosis requiring posterior cervical arthrodesis.

Probably not a fit

Patients with traumatic injuries, severe co-morbidities, or those on medications that interfere with healing may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study evaluates fusion rates and cervical sagittal parameters in patients undergoing posterior cervical arthrodesis supplemented with interfacet spacers. Data will be collected from medical records for up to 730 days post-surgery, including demographic, clinical, surgical, and radiographic information. Additionally, patients will receive a non-standard CT scan two years after their surgery to assess long-term outcomes. The study aims to address complications associated with cervical fusion, such as foraminal stenosis and C5 palsy.

Why it matters

Potential benefit: If successful, this study could improve surgical outcomes and reduce complications for patients undergoing cervical fusion.

How similar studies have gone: While the use of interfacet spacers is a novel approach in this context, similar studies have shown promising results in improving foraminal height and reducing complications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years old
* Symptomatic multi-level degenerative spondylosis necessitating posterior cervical arthrodesis in the subaxial cervicothoracic spine (between C2-upper thoracic).
* Surgery performed within the Department of Neurological Surgery at The Ohio State University Wexner Medical Center (OSUWMC)

Exclusion Criteria:

* Traumatic injury
* Co-morbidity requiring medication use that may interfere with bone or soft tissue healing (i.e., high dose oral or parenteral glucocorticoids, immunosuppressive agents, methotrexate) - at discretion of investigator
* Severe co-morbidities (e.g., heart, respiratory, or renal disease)
* Recent (\<3 yrs) or co-incident spinal tumor or infection
* Concurrent involvement in another investigational drug or device study that could confound study data
* History of substance abuse (recreational drugs, prescription drugs or alcohol) that could interfere with protocol assessments and/or with the subject's ability to complete the protocol required follow-up
* Subjects who are pregnant or plan to become pregnant in the next 24 months
* Prisoner

Where it's running

  • The Ohio State University Wexner Medical Center
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.